Connect
MJA
MJA

Treatment outcomes for Indigenous and non-Indigenous inmates with hepatitis C in New South Wales prisons

Jeffrey J Post, Andrew R Lloyd and Denise Monkley
Med J Aust 2013; 199 (7): 464. || doi: 10.5694/mja13.10925

To the Editor: Davis and colleagues recently described outcomes for Indigenous and non-Indigenous people in the Northern Territory who received antiviral therapy for chronic hepatitis C virus (HCV) infection.1 They showed similar outcomes when comparing eight Indigenous people with 88 non-Indigenous people who were assessed for sustained virological response (SVR) after interferon-based treatment — SVR was achieved by 50% and 61%, respectively. Outcomes of therapy for HCV infection in Indigenous Australians had not previously been reported.

  • Jeffrey J Post1,2
  • Andrew R Lloyd2,3
  • Denise Monkley2

  • 1 Prince of Wales Clinical School, University of New South Wales, Sydney, NSW.
  • 2 Justice Health and Forensic Mental Health Network, Sydney, NSW.
  • 3 Inflammation and Infection Research Centre, University of New South Wales, Sydney, NSW.

Correspondence: j.post@unsw.edu.au

Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.